Béatrice Dubern

发表

Evaluation of a melanocortin-4 receptor (MC4R) agonist (Setmelanotide) in MC4R deficiency

K. Clément, S. O’Rahilly, R. Cone, 2017, Molecular metabolism.

Deficiency in prohormone convertase PC 1 impairs prohormone processing in Prader-Willi syndrome

C. Poitou, Daniel Paull, A. Skowronski, 2022 .

Efficacy and safety of setmelanotide, an MC4R agonist, in individuals with severe obesity due to LEPR or POMC deficiency: single-arm, open-label, multicentre, phase 3 trials.

W. Chung, K. Clément, I. Farooqi, 2020, The lancet. Diabetes & endocrinology.

Eating behaviour in obese patients with melanocortin-4 receptor mutations: a literature review

K. Clément, F. Bellisle, S. Czernichow, 2013, International Journal of Obesity.